Medpace
MEDP
610.54
-23.44
-3.70%
Medpace
US · MEDP
#1015 by market cap
Listed 2016
610.54
-23.44
-3.70%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Quant vs Street three independent views, side by side
StockVane factor grade
B+
Momentum strategy signal
Hold
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
✦ Quant Analyst Revision Trend how this is computed
Improving
4 1
■ Upgrades■ Downgrades
- 4 upgrades vs 1 downgrade among tracked analyst rating changes.
- Most recent: Baird moved from Hold to Buy on 2026-10-23.
Analyst consensus 8 analysts
Buy
Avg price target 691.29 +13.2%
Price target rangecurrent 610.54
Low670.00
Avg691.29
High730.00
Buy 38%
Hold 63%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-26 | BMO Capital | -- | Hold | 670.00 |
| 2026-10-23 | TD Cowen | -- | Hold | 673.00 |
| 2026-10-23 | UBS | -- | Hold | 700.00 |
| 2026-10-23 | Mizuho Securities | -- | Buy | 730.00 |
| 2026-10-23 | Baird | -- | Buy | 699.00 |
| 2026-10-23 | Barclays | -- | Hold | 675.00 |
| 2026-10-22 | RBC Capital | -- | Buy | 692.00 |
| 2026-10-07 | Mizuho Securities | -- | Buy | 700.00 |
| 2026-10-07 | Barclays | -- | Hold | 625.00 |
| 2026-10-06 | RBC Capital | -- | Buy | 692.00 |
| 2026-10-02 | UBS | -- | Hold | 673.00 |
| 2026-09-30 | UBS | -- | Hold | 673.00 |
| 2026-09-17 | Truist Financial | -- | Hold | -- |
| 2026-07-28 | Mizuho Securities | -- | Buy | 665.00 |
| 2026-07-28 | Truist Financial | -- | Hold | 609.00 |
| 2026-07-24 | Mizuho Securities | -- | Buy | 665.00 |
| 2026-07-24 | Truist Financial | -- | Hold | 609.00 |
| 2026-07-24 | Baird | -- | Hold | 624.00 |
| 2026-07-23 | William Blair | -- | Hold | -- |
| 2026-07-23 | Truist Financial | -- | Hold | -- |
| 2026-07-23 | Deutsche Bank | -- | Hold | 535.00 |
| 2026-07-23 | BMO Capital | -- | Hold | 600.00 |
| 2026-07-23 | Leerink Partners | -- | Hold | 620.00 |
| 2026-07-23 | RBC Capital | -- | Buy | 692.00 |
| 2026-07-22 | William Blair | -- | Hold | -- |
Price target trend monthly average, last 3 years
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-10-23 | Baird | Hold → Buy | 699.00 |
| 2026-10-23 | TD Cowen | Sell → Hold | 673.00 |
| 2026-07-08 | Baird | Buy → Hold | 547.00 |
| 2026-03-06 | Barclays | Sell → Hold | 500.00 |
| 2026-02-10 | Baird | Hold → Buy | 564.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-10-21 | After close | ±13.79% | -1.29% (in line) |
| 2026/Q2 | 2026-07-22 | After close | ±15.30% | +14.71% (in line) |
| 2026/Q1 | 2026-04-22 | After close | ±14.69% | -22.63% (beat) |
| 2025/Q4 | 2026-02-09 | After close | ±11.56% | -15.90% (beat) |
| 2025/Q3 | 2025-10-22 | After close | ±13.98% | +9.12% (in line) |
| 2025/Q2 | 2025-07-21 | After close | ±13.70% | +54.67% (beat) |
| 2025/Q1 | 2025-04-21 | After close | ±15.75% | -2.32% (in line) |
| 2024/Q4 | 2025-02-10 | After close | ±11.60% | -7.52% (in line) |
| 2024/Q3 | 2024-10-21 | After close | ±15.79% | -7.47% (in line) |
| 2024/Q2 | 2024-07-22 | After close | ±13.00% | -18.27% (beat) |
| 2024/Q1 | 2024-04-22 | After close | ±13.36% | +8.21% (in line) |
| 2023/Q4 | 2024-02-12 | After close | ±12.20% | +12.30% (beat) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Medpace discussion 0 comments